A phase II trial of PALA+dipyridamole in patients with advanced soft-tissue sarcoma
- 1 January 1991
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 28 (1) , 51-54
- https://doi.org/10.1007/bf00684956
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Enhancement of fluorouracil therapy by the manipulation of tissue uridine poolsPharmacology & Therapeutics, 1989
- Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1987
- Phase I trial of combination therapy of cancer with N-phosphanacetyl-L-aspartic acid and dipyridamoleCancer Chemotherapy and Pharmacology, 1987
- Phase II evaluation of PALA in patients with refractory metastatic sarcomasAmerican Journal of Clinical Oncology, 1984
- Dipyridamole kineticsClinical Pharmacology & Therapeutics, 1982
- High-performance liquid chromatographic analysis of dipyridamole in plasma and whole bloodJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Permeation of Nucleosides, Nucleic Acid Bases, and Nucleotides in Animal CellsPublished by Elsevier ,1980
- Uridine transport in novikoff rat hepatoma cells and other cell lines and its relationship to uridine phosphorylation and phosphorolysisJournal of Cellular Physiology, 1978
- Binding of Dipyridamole to Human Platelets and to α1 Acid Glycoprotein and its Significance for the Inhibition of Adenosine UptakeJournal of Clinical Investigation, 1977
- Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-aspartate in vivoBiochemical Pharmacology, 1977